According to the business intelligence report titled ‘Global Intragastric Balloon Market 2019-2028’, available with Market Study Report, global intragastric balloon market is slated to grow at 12.33% CAGR through 2028.
 

As per the report findings, escalating demand for weight loss solutions due to increasing obesity arising from inactive lifestyle and unhealthy diets is catalyzing global intragastric balloon market growth. Short recovery time along with quick and non-invasive nature of the procedure are enhancing the demand.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552678/
 

While rising investments by governments to reduce obesity will aid industry expansion, stomach ulcers and temporary nature of treatment are poised to act as challenges for businesses in this domain.
 

The research document studies the market extensively by diving it into segments. Growth rate estimates, market share captured by each segment and their valuation is provided as well.
 

Based on component, the industry is divided into triple balloon, dual balloon, and single balloon. Speaking of application scope, the market sphere is fragmented into hospitals, ambulatory surgical centers, and clinics. Moving on to filling material, the business sphere is split into saline-filled, and gas-filled.
 

From the regional frame of reference, Asia Pacific intragastric balloon market is projected to witness significant growth between 2019-2028 owing to rising obesity rates as a result of sedentary lifestyle and unhealthy diet. This in turn has increased cases of heart diseases, diabetes, and stroke, further enahncing demand for weight loss methods in the region.
 

North America, Europe, Latin America, and Middle East & Africa are the other major regions covered in the research literature.
 

Elaborating on the competitive landscape, Apollo Endosurgery Inc., Baronova Inc., Medsil (Medispar), Spatz FGIA Inc., Helioscopie, ReShape Lifesciences Inc., Aspire Bariatrics Inc., Endalis, Districlass Medical SA, Obalon Therapeutics Inc., AbbVie Inc., Allurion Technologies, and Silimed Inc. are the key players impacting the global intragastric balloon industry dynamics.
 

These companies have undertaken strategic moves like mergers & acquisitions, collaborations, investments in research & development, partnerships, alliances, and launch of innovative products to garner massive revenues and gain a competitive advantage.